Global Cardiac Bio Implant Devices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 55.08 Billion |
 Market Size (Forecast Year) |
USD 119.99 Billion |
 CAGR |
% |
| Major Markets Players |
>全球心脏生物植入设备市场，按产品（结构性心脏植入物、支架和相关植入物、起搏装置）、疾病（心肌缺血、急性心肌梗死、心律失常、充血性心力衰竭 (CHF)、心绞痛 (AP)、心肌病、主动脉瘤等）、程序（血管成形术、心脏瓣膜修复或置换、开胸手术、微创心脏手术、心脏再同步治疗 (CRT)、其他）、国家（美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区）行业趋势和预测到 2028 年
市场分析与洞察：全球心脏生物植入设备市场
心脏生物植入设备市场预计将在 2021 年至 2028 年的预测期内实现市场增长。数据桥市场研究分析，在 2021 年至 2028 年的预测期内，该市场以 10.22% 的复合年增长率增长，预计到 2028 年将达到 81,3036.7 亿美元。全球心血管疾病患病率的上升正在推动心脏生物植入设备市场的增长。
心脏病是指与血管和心脏有关的疾病，例如先天性心脏缺陷、冠状动脉疾病和心律失常等。心脏病最常见的病因被认为是血管和冠状动脉变窄或阻塞，也称为缺血性心脏病。高胆固醇、吸烟和高血压也可能引起心脏病。糖尿病和肥胖以及营养不良、酗酒和缺乏运动等生活方式的改变会增加患心脏病的风险。心血管植入物具有独特的血液生物相容性，可确保该装置不会因不良的血栓形成或血流动力学血液反应而被排斥。
The increasing prevalence of chronic heart ailments among people, sedentary lifestyles and growing geriatric population globally are the major factors driving the growth of cardiac bio implant devices market. The growth in the awareness and need of bio-engineered products for treatment of diseases, the technological advancements and rise in investments for the development and manufacturing of cardiac bio-implant devices accelerate the cardiac bio implant devices market growth. The change in lifestyle such as excessive alcohol consumption, smoking and unhealthy diet habits causing heart problems, growing number of research and development activities and increase in the occurrence of heart problems due to obesity and lack of physical activities influence the cardiac bio implant devices market. Additionally, growth in global population, rise in awareness regarding the disease and treatment, high mortality rate, increase in healthcare expenditure and surge in disposable income of people positively affect the cardiac bio implant devices market. Furthermore, advanced research and development activities, new product developments and emerging economies extends profitable opportunity to the cardiac bio implant devices market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the cardiac bio-implant devices and the complications associated with the usage of these devices are factors expected to obstruct the cardiac bio implant devices market growth. The implementation of stringent regulatory requirements for the approval of cardiac bio-implant devices is projected to challenge the cardiac bio implant devices market in the forecast period of 2021 to 2028.
This cardiac bio implant devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cardiac bio implant devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Cardiac Bio Implant Devices Market Scope and Market Size
The cardiac bio implant devices market is segmented on the basis of product, disease and procedure. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
-
On the basis of product, the cardiac bio implant devices market is segmented into structural cardiac implants, stents and related implants and pacing devices. Structural cardiac implants are further segmented into ventricular-assist devices, heart valves, accessories, and insertable loop recorders/implantable heart monitors. Stents and related implants are further segmented into stent-related implants, coronary stents and peripheral stents. Pacing devices are further segmented into implantable cardiac pacemakers (ICPs), implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs) and pacing accessories.
- On the basis of disease, the cardiac bio implant devices market is segmented into myocardial ischemia, acute myocardial infarction, arrhythmias, congestive heart failure (CHF), angina pectoris (AP), cardiomyopathy, aortic aneurism and others. Acute myocardial infarction is further segmented into atrial fibrillation, ventricular fibrillation and ventricular tachycardia. Angina pectoris (AP) is further segmented into stable angina and unstable angina.
- On the basis of procedure, the cardiac bio implant devices market is segmented into angioplasty, heart valve repair or replacement, open heart surgery, minimally invasive heart surgery, cardiac resynchronization therapy (CRT) and other.
Global Cardiac Bio Implant Devices Market Country Level Analysis
The cardiac bio implant devices market is analyzed and market size insights and trends are provided by country, product, disease and procedure as referenced above.
The countries covered in the global cardiac bio implant devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates cardiac bio implant devices market because of the large number of aging population and lifestyle associated diseases. Asia-Pacific is expected to witness high growth during the forecast period of 2021-2028 due to the large pool of patients, increased government funding and increasing healthcare expenditure.
心脏生物植入设备市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
心脏生物植入设备市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、心脏生物植入设备市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对心脏生物植入设备市场的影响。数据涵盖 2011-2019 年的历史时期。
竞争格局和心脏生物植入设备市场份额分析
心脏生物植入设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对心脏生物植入设备市场的关注有关。
心脏生物植入设备市场报告中涉及的主要参与者包括雅培、爱德华生命科学公司、强生服务公司、LivaNova PLC、美敦力、波士顿科学公司、微创科学公司、梅奥医学教育和研究基金会 (MFMER)、ClearPoint Neuro, Inc.、Imricor、BIOTRONIK、Bentley、Elestim-Cardio、QualiMed、MEDICO SpA、乐普医疗科技（北京）有限公司、戈尔公司、LifeNet Health 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
